Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review.

about

Diabetes drugs and the incidence of solid cancers: a survey of the current evidence.

P2860

Q38651175-23C1A087-2677-44DE-9896-836394948E89

P2860

Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review.

Item

http://www.wikidata.org/entity/Q38858585

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Cancer risk of sulfonylureas i ...... mellitus: A systematic review.

@en

type

Item

label

Cancer risk of sulfonylureas i ...... mellitus: A systematic review.

@en

prefLabel

Cancer risk of sulfonylureas i ...... mellitus: A systematic review.

@en

P1476

Cancer risk of sulfonylureas i ...... mellitus: A systematic review.

@en

P2093

Guanjian Liu

http://www.w3.org/2001/XMLSchema#string

Jun Ma

http://www.w3.org/2001/XMLSchema#string

Liang Du

http://www.w3.org/2001/XMLSchema#string

Ling Li

http://www.w3.org/2001/XMLSchema#string

Xin Sun

http://www.w3.org/2001/XMLSchema#string

Xingyuan Geng

http://www.w3.org/2001/XMLSchema#string

Xun Yao

http://www.w3.org/2001/XMLSchema#string

Yuehong Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis

Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth

Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.

Latest insights into the risk of cancer in diabetes

Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes.

Incidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas.

Long-term metformin use is associated with decreased risk of breast cancer.

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.

P304

482-494

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1753-0407.12435

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27273872

http://www.w3.org/2001/XMLSchema#string

Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review.

about

P2860

P2860

Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698